tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Venture Life Buys Back 200,000 Shares for Treasury Under Ongoing Programme

Story Highlights
  • Venture Life repurchased 200,000 shares at 67 pence, held as treasury stock.
  • Post-buyback, the company has 124,439,345 voting shares outstanding for disclosure calculations.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Venture Life Buys Back 200,000 Shares for Treasury Under Ongoing Programme

Claim 50% Off TipRanks Premium

Venture Life ( (GB:VLG) ) just unveiled an announcement.

Venture Life Group has continued to execute its share buyback programme, repurchasing 200,000 ordinary shares at a volume-weighted average price of 67 pence per share through Cavendish Capital Markets, with the acquired stock to be held in treasury. Following this transaction, the company now has 128,812,145 ordinary shares in issue, of which 4,372,800 are held in treasury, leaving 124,439,345 voting rights in circulation, a figure that shareholders can use to assess and report any changes in their notifiable holdings under regulatory disclosure rules.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £69.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on GB:VLG Stock

According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on GB:VLG stock, click here.

More about Venture Life

Venture Life Group plc is a UK-headquartered international consumer self-care company operating in the global consumer healthcare sector, focused on proactive healthy longevity, product innovation, development and commercialisation. Its portfolio includes brands such as Balance Activ in women’s intimate healthcare, Earol for ENT care, Lift and Glucogel for energy and glucose management and hypoglycaemia, and the Health & Her range supporting the hormonal lifecycle, with products sold through pharmacies, health & beauty retailers, grocery chains and e-commerce channels worldwide via direct supply in key markets and international distribution partners elsewhere.

Average Trading Volume: 243,413

Technical Sentiment Signal: Buy

Current Market Cap: £84.24M

For detailed information about VLG stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1